California legislation
This article was originally published in The Rose Sheet
Executive Summary
Phthalates Free Cosmetics Act (AB 908), which would ban the use of di-butyl phthalate and di-(2-ethylhexyl) phthalate in cosmetics and personal care products in California, will be addressed by the Assembly Committee on Health May 3 (1"The Rose Sheet" April 4, 2005, p. 3). Authored by Assembly Member Judy Chu (D-49th), bill is similar to previous legislation introduced by Chu seeking to regulate cosmetic ingredients. Additionally, California Senate Health Committee postpones review of the California Safe Cosmetics Act of 2005 (SB 484), which was scheduled for an April 13 hearing. SB 484, introduced March 30 by Sen. Carol Migden (D-3rd), seeks to regulate the use of chemicals known to cause cancer or reproductive toxicity in cosmetics sold in the state...
You may also be interested in...
California Dreaming? Dems Re-Introduce Legislation To Regulate Cosmetics
Manufacturers of cosmetics subject to FDA regulation and sold in California would be required to report to the Department of Health Services any ingredient containing a chemical known to the state as causing cancer or reproductive toxicity under legislation pending in the state senate
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.